KRAS mRNA-LNP Vaccine Manufacturing Support
- Research Category Research & Development Services & Subcontracts
- Solicitation Number S24-027
- NCI OA Contract Number 75N91019D00024 – NCI-FFRDC
Description
The overall objective of this Solicitation is to develop and/or implement a process for and manufacture of one KRAS mRNA-LNP vaccine under cGMP conditions for use in a future Phase I Clinical Trial in human subjects.
Proposal Instructions
Solicitation Questions and Clarifications due no later than 2:00pm (EST) on March 7, 2024
Offeror's Pre-Submission Teleconference to be held at 2:00pm (EST) on March 11, 2024
Offer submissions are due no later than 2:00pm (EST) on March 28, 2024
Contact the POC, Ms. Shaneeka Owens at shaneeka.owens-bearden@nih.gov if interested in receiving the Full Solicitation Package
Modified By | Date Modified Sort ascending | Comment |
---|---|---|
Shaneeka Owens | S24-027 Solicitation Amendment #1 was issued on 3/25/2024 providing responses to received questions, revisions to the Statement of Work and extending the offer due date. All offers are now due no later than 2:00pm (ET) on Thursday, April 11, 2024. |